Xenon Pharmaceuticals Inc. - Common Stock (XENE)
CUSIP: 98420N105
Q1 2017 13F Holders as of 31 Mar 2017
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 76,851,274
- Total 13F shares
- 10,076,433
- Share change
- -416,573
- Total reported value
- $40,304,200
- Price per share
- $4.00
- Number of holders
- 37
- Value change
- -$3,171,773
- Number of buys
- 14
- Number of sells
- 17
Quarterly Holders Quick Answers
What is CUSIP 98420N105?
CUSIP 98420N105 identifies XENE - Xenon Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420N105:
Top shareholders of XENE - Xenon Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
4%
|
3,043,805
|
$23,437,000 | — | 31 Dec 2016 | |
| Capital World Investors |
13F
|
Company |
1.6%
|
1,225,000
|
$9,433,000 | — | 31 Dec 2016 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.3%
|
1,000,000
|
$7,700,000 | — | 31 Dec 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.96%
|
740,272
|
$5,700,000 | — | 31 Dec 2016 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.91%
|
700,000
|
$5,390,000 | — | 31 Dec 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.67%
|
514,091
|
$3,959,000 | — | 31 Dec 2016 | |
| Opaleye Management Inc. |
13F
|
Company |
0.53%
|
405,000
|
$3,119,000 | — | 31 Dec 2016 | |
| Invesco Private Capital, Inc. |
13F
|
Company |
0.52%
|
400,677
|
$3,085,000 | — | 31 Dec 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.43%
|
328,029
|
$2,526,000 | — | 31 Dec 2016 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.42%
|
325,000
|
$2,503,000 | — | 31 Dec 2016 | |
| INTERWEST VENTURE MANAGEMENT CO |
13F
|
Company |
0.42%
|
320,061
|
$2,465,000 | — | 31 Dec 2016 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.4%
|
310,179
|
$2,388,000 | — | 31 Dec 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.32%
|
246,277
|
$1,897,000 | — | 31 Dec 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.25%
|
193,674
|
$1,491,000 | — | 31 Dec 2016 | |
| Novo Holdings A/S |
13F
|
Company |
0.17%
|
127,563
|
$982,000 | — | 31 Dec 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.15%
|
114,200
|
$879,000 | — | 31 Dec 2016 | |
| HIGHLAND CAPITAL MANAGEMENT LP |
13F
|
Company |
0.14%
|
110,213
|
$848,000 | — | 31 Dec 2016 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.09%
|
70,172
|
$540,000 | — | 31 Dec 2016 | |
| State of New Jersey Common Pension Fund D |
13F
|
Company |
0.08%
|
65,000
|
$501,000 | — | 31 Dec 2016 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.07%
|
57,228
|
$441,000 | — | 31 Dec 2016 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.07%
|
55,000
|
$424,000 | — | 31 Dec 2016 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
34,928
|
$269,000 | — | 31 Dec 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.04%
|
31,500
|
$243,000 | — | 31 Dec 2016 | |
| SCOTIA CAPITAL INC. |
13F
|
Company |
0.03%
|
20,818
|
$160,000 | — | 31 Dec 2016 | |
| NJ State Employees Deferred Compensation Plan |
13F
|
Company |
0.03%
|
20,000
|
$154,000 | — | 31 Dec 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
12,762
|
$98,000 | — | 31 Dec 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
10,020
|
$77,000 | — | 31 Dec 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
7,137
|
$56,000 | — | 31 Dec 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,514
|
$19,000 | — | 31 Dec 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,136
|
$9,000 | — | 31 Dec 2016 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
700
|
$5,000 | — | 31 Dec 2016 |
Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q1 2017
As of 31 Mar 2017,
Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,076,433 shares.
The largest 10 holders included
BVF INC/IL, Capital World Investors, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, Alyeska Investment Group, L.P., Invesco Private Capital, Inc., Opaleye Management Inc., Tekla Capital Management LLC, Endurant Capital Management LP, and DAFNA Capital Management LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2017 vs Q4 2016 Across Filers
Q4 2016 holders
31
Q1 2017 holders
37
Holder diff
6
| Investor | Q4 2016 Shares | Q1 2017 Shares | Share Diff | Share Chg % | Q4 2016 Value $ | Q1 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.